vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($48.6M vs $44.5M, roughly 1.1× Cronos Group Inc.). Ouster, Inc. runs the higher net margin — 8.2% vs -4.1%, a 12.3% gap on every dollar of revenue. On growth, Ouster, Inc. posted the faster year-over-year revenue change (48.9% vs 47.0%). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (34.2% CAGR vs 32.7%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
CRON vs OUST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $48.6M |
| Net Profit | $-1.8M | $4.0M |
| Gross Margin | 36.4% | 42.9% |
| Operating Margin | -16.8% | 17.6% |
| Net Margin | -4.1% | 8.2% |
| Revenue YoY | 47.0% | 48.9% |
| Net Profit YoY | -104.2% | — |
| EPS (diluted) | $-0.01 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $48.6M | ||
| Q4 25 | $44.5M | $62.2M | ||
| Q3 25 | $36.3M | $39.5M | ||
| Q2 25 | $33.5M | $35.0M | ||
| Q1 25 | $32.3M | $32.6M | ||
| Q4 24 | $30.3M | $30.1M | ||
| Q3 24 | $34.3M | $28.1M | ||
| Q2 24 | $27.8M | $27.0M |
| Q1 26 | — | $4.0M | ||
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $26.0M | $-21.7M | ||
| Q2 25 | $-39.7M | $-20.6M | ||
| Q1 25 | $6.1M | $-22.0M | ||
| Q4 24 | $43.7M | — | ||
| Q3 24 | $8.3M | $-25.6M | ||
| Q2 24 | $-8.8M | $-23.9M |
| Q1 26 | — | 42.9% | ||
| Q4 25 | 36.4% | 60.2% | ||
| Q3 25 | 50.4% | 42.1% | ||
| Q2 25 | 43.4% | 45.2% | ||
| Q1 25 | 42.6% | 41.3% | ||
| Q4 24 | 35.7% | 43.8% | ||
| Q3 24 | 10.5% | 38.3% | ||
| Q2 24 | 22.7% | 33.7% |
| Q1 26 | — | 17.6% | ||
| Q4 25 | -16.8% | 1.5% | ||
| Q3 25 | -1.4% | -61.4% | ||
| Q2 25 | -15.9% | -76.5% | ||
| Q1 25 | -12.6% | -73.0% | ||
| Q4 24 | -37.5% | -85.1% | ||
| Q3 24 | -98.2% | -98.0% | ||
| Q2 24 | -56.1% | -93.6% |
| Q1 26 | — | 8.2% | ||
| Q4 25 | -4.1% | — | ||
| Q3 25 | 71.4% | -55.0% | ||
| Q2 25 | -118.7% | -58.8% | ||
| Q1 25 | 19.0% | -67.5% | ||
| Q4 24 | 144.3% | — | ||
| Q3 24 | 24.4% | -91.1% | ||
| Q2 24 | -31.5% | -88.4% |
| Q1 26 | — | $0.06 | ||
| Q4 25 | $-0.01 | $0.10 | ||
| Q3 25 | $0.07 | $-0.37 | ||
| Q2 25 | $-0.10 | $-0.38 | ||
| Q1 25 | $0.02 | $-0.42 | ||
| Q4 24 | $0.12 | $-0.46 | ||
| Q3 24 | $0.02 | $-0.54 | ||
| Q2 24 | $-0.02 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | $173.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $275.6M |
| Total Assets | $1.2B | $381.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $173.1M | ||
| Q4 25 | $831.8M | $208.6M | ||
| Q3 25 | $824.2M | $244.5M | ||
| Q2 25 | $834.4M | $226.5M | ||
| Q1 25 | $837.8M | $168.2M | ||
| Q4 24 | $858.8M | $172.0M | ||
| Q3 24 | $862.0M | $151.4M | ||
| Q2 24 | $848.2M | $184.2M |
| Q1 26 | — | $275.6M | ||
| Q4 25 | $1.1B | $261.7M | ||
| Q3 25 | $1.1B | $247.4M | ||
| Q2 25 | $1.1B | $221.0M | ||
| Q1 25 | $1.1B | $167.9M | ||
| Q4 24 | $1.1B | $180.9M | ||
| Q3 24 | $1.1B | $171.7M | ||
| Q2 24 | $1.1B | $170.6M |
| Q1 26 | — | $381.5M | ||
| Q4 25 | $1.2B | $349.5M | ||
| Q3 25 | $1.2B | $353.8M | ||
| Q2 25 | $1.2B | $321.8M | ||
| Q1 25 | $1.2B | $268.6M | ||
| Q4 24 | $1.2B | $276.1M | ||
| Q3 24 | $1.2B | $255.2M | ||
| Q2 24 | $1.1B | $309.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | — |
| Free Cash FlowOCF − Capex | $9.7M | — |
| FCF MarginFCF / Revenue | 21.8% | — |
| Capex IntensityCapex / Revenue | 4.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.8M | $-15.4M | ||
| Q3 25 | $13.3M | $-18.3M | ||
| Q2 25 | $2.8M | $-1.3M | ||
| Q1 25 | $-2.1M | $-4.9M | ||
| Q4 24 | $7.7M | $-2.6M | ||
| Q3 24 | $11.6M | $-3.8M | ||
| Q2 24 | $1.7M | $-21.6M |
| Q1 26 | — | — | ||
| Q4 25 | $9.7M | $-37.2M | ||
| Q3 25 | $8.8M | $-20.0M | ||
| Q2 25 | $-1.0M | $-2.2M | ||
| Q1 25 | $-17.4M | $-5.4M | ||
| Q4 24 | $4.2M | $-4.0M | ||
| Q3 24 | $5.2M | $-4.3M | ||
| Q2 24 | $1.0M | $-22.0M |
| Q1 26 | — | — | ||
| Q4 25 | 21.8% | -59.8% | ||
| Q3 25 | 24.3% | -50.7% | ||
| Q2 25 | -3.0% | -6.3% | ||
| Q1 25 | -53.8% | -16.6% | ||
| Q4 24 | 13.8% | -13.3% | ||
| Q3 24 | 15.1% | -15.4% | ||
| Q2 24 | 3.7% | -81.5% |
| Q1 26 | — | — | ||
| Q4 25 | 4.8% | 35.0% | ||
| Q3 25 | 12.3% | 4.3% | ||
| Q2 25 | 11.5% | 2.5% | ||
| Q1 25 | 47.3% | 1.7% | ||
| Q4 24 | 11.7% | 4.8% | ||
| Q3 24 | 18.7% | 2.0% | ||
| Q2 24 | 2.6% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
OUST
| Product revenue | $48.2M | 99% |
| Royalties | $347.0K | 1% |
